Group One Trading’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54 Sell
100
-22,600
-100% -$16.6K ﹤0.01% 7448
2025
Q4
$18K Sell
22,700
-5,900
-21% -$5.8K ﹤0.01% 6423
2025
Q3
$29.7K Buy
28,600
+28,100
+5,620% +$29.5K ﹤0.01% 6377
2025
Q2
$332 Sell
500
-100
-17% -$67 ﹤0.01% 7699
2025
Q1
$342 Sell
600
-4,200
-88% -$3.31K ﹤0.01% 7330
2024
Q4
$4.22K Buy
4,800
+600
+14% +$802 ﹤0.01% 6480
2024
Q3
$4.62K Buy
+4,200
New +$9.46K ﹤0.01% 5908
2023
Q1
Sell
-300
Closed -$1.49K 7979
2022
Q4
$1.49K Sell
300
-100
-25% -$606 ﹤0.01% 6740
2022
Q3
$2K Buy
400
+300
+300% +$1.93K ﹤0.01% 7211
2022
Q2
$1K Sell
100
-480
-83% -$2.93K ﹤0.01% 7630
2022
Q1
$3K Sell
580
-860
-60% -$4.95K ﹤0.01% 7655
2021
Q4
$10K Sell
1,440
-780
-35% -$7.37K ﹤0.01% 7359
2021
Q3
$24K Buy
2,220
+200
+10% +$2.35K ﹤0.01% 7072
2021
Q2
$30K Buy
2,020
+1,440
+248% +$24K ﹤0.01% 6959
2021
Q1
$11K Sell
580
-620
-52% -$14.9K ﹤0.01% 7025
2020
Q4
$23K Buy
1,200
+1,100
+1,100% +$18.2K ﹤0.01% 5451
2020
Q3
$1K Sell
100
-3,280
-97% -$38K ﹤0.01% 5964
2020
Q2
$37K Buy
+3,380
New +$25.8K ﹤0.01% 4541
2016
Q4
Sell
-40
Closed -$3K 4853
2016
Q3
$3K Buy
40
+20
+100% +$1.25K ﹤0.01% 4323
2016
Q2
$1K Hold
20
﹤0.01% 4523
2016
Q1
$1K Buy
+20
New +$1.06K ﹤0.01% 4456
2015
Q3
Sell
-20
Closed -$2K 5199
2015
Q2
$2K Sell
20
-200
-91% -$17.3K ﹤0.01% 4678
2015
Q1
$21K Sell
220
-3,000
-93% -$277K ﹤0.01% 3861
2014
Q4
$282K Buy
3,220
+1,800
+127% +$155K ﹤0.01% 2020
2014
Q3
$130K Buy
1,420
+600
+73% +$65K ﹤0.01% 2768
2014
Q2
$94K Sell
820
-120
-13% -$14.2K ﹤0.01% 3049
2014
Q1
$114K Sell
940
-1,260
-57% -$165K ﹤0.01% 2958
2013
Q4
$277K Buy
2,200
+720
+49% +$86.4K ﹤0.01% 2148
2013
Q3
$161K Buy
+1,480
New +$144K ﹤0.01% 2572

Other funds holding TRIB

Group One Trading's TRIB Position: Q4 2023 in Review

Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 3,338 shares — an estimated $12.2K sold.

Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.

  • Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 3,338 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
  • Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
  • 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.